25-Hydroxyvitamin D Levels and the Risk of Stroke A Prospective Study and Meta-analysis

被引:139
|
作者
Sun, Qi [1 ,3 ]
Pan, An [1 ]
Hu, Frank B. [1 ,2 ,3 ]
Manson, Joann E. [2 ,3 ,4 ]
Rexrode, Kathryn M. [4 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
meta-analysis; stroke; vitamin D; VITAMIN-D SUPPLEMENTATION; 1,25-DIHYDROXYVITAMIN D-3; NURSES HEALTH; D DEFICIENCY; WOMEN; D-3-1-ALPHA-HYDROXYLASE; CHOLECALCIFEROL; EXPRESSION; PATTERNS; ARTERIES;
D O I
10.1161/STROKEAHA.111.636910
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Despite evidence suggesting that vitamin D deficiency may lead to elevated cardiovascular disease risk, results regarding the association of 25-hydroxyvitamin D (25[OH] D) levels with stroke risk are inconclusive. We aimed to examine this association in a prospective study in women and to summarize all existing data in a meta-analysis. Methods-We measured 25(OH) D levels among 464 women who developed ischemic stroke and an equal number of control subjects who were free of stroke through 2006 in the Nurses' Health Study (NHS). We searched MEDLINE and EMBASE for articles published through March 2011 that prospectively evaluated 25(OH) D levels in relation to stroke. Results-After multivariable adjustment for lifestyle and dietary covariates, lower 25(OH) D levels were associated with an elevated risk of ischemic stroke in the NHS: the OR (95% CI) comparing women in the lowest versus highest tertiles was 1.49 (1.01-2.18; P-trend = 0.04). We found 6 other prospective studies that examined 25(OH) D in relation to stroke outcomes. After pooling our results with these prospective studies that included 1214 stroke cases in total, low 25(OH) D levels were associated with increased risk of developing stroke outcomes in comparison to high levels: the pooled relative risk (95% CI) was 1.52 (1.20-1.85; I-2 = 0.0%, P-heterogeneity = 0.63). In 2 studies that explicitly examined ischemic stroke, this association was 1.59 (1.07-2.12; I-2 = 0.0%, P-heterogeneity = 0.80). Conclusions-These data provide evidence that low vitamin D levels are modestly associated with risk of stroke. Maintaining adequate vitamin D status may lower the risk of stroke in women. (Stroke. 2012; 43: 1470-1477.)
引用
收藏
页码:1470 / +
页数:18
相关论文
共 50 条
  • [41] 25-Hydroxyvitamin D Concentrations and Clostridium difficile Infection: A Meta-Analysis
    Furuya-Kanamori, Luis
    Wangdi, Kinley
    Yakob, Laith
    McKenzie, Samantha J.
    Doi, Suhail A. R.
    Clark, Justin
    Paterson, David L.
    Riley, Thomas V.
    Clements, Archie C. A.
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2017, 41 (05) : 890 - 895
  • [42] 25-Hydroxyvitamin D and osteoarthritis: A meta-analysis including new data
    Bergink, Arjan P.
    Zillikens, M. Carola
    Van Leeuwen, Johannes P. T. M.
    Hofman, Albert
    Uitterlinden, Andre G.
    van Meurs, Joyce B. J.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 45 (05) : 539 - 546
  • [43] Serum 25-Hydroxyvitamin D Concentration and Cognitive Impairment
    Llewellyn, David J.
    Langa, Kenneth M.
    Lang, Iain A.
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2009, 22 (03) : 188 - 195
  • [44] Serum/plasma 25-hydroxyvitamin D and risk of lung, breast and prostate cancer: a meta-analysis
    Liu, Jing
    Huang, Wenhui
    Zhou, Ruoyu
    Jia, Shuting
    Tang, Wenru
    Luo, Ying
    Zhang, Jihong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 2728 - 2737
  • [45] Circulating 25-Hydroxyvitamin D and Risk of Endometrial Cancer
    Zeleniuch-Jacquotte, Anne
    Gallicchio, Lisa
    Hartmuller, Virginia
    Helzlsouer, Kathy J.
    McCullough, Marjorie L.
    Setiawan, V. Wendy
    Shu, Xiao-Ou
    Weinstein, Stephanie J.
    Weiss, Jocelyn M.
    Arslan, Alan A.
    De Vivo, Immaculata
    Gao, Yu-Tang
    Hayes, Richard B.
    Henderson, Brian E.
    Horst, Ronald L.
    Koenig, Karen L.
    Patel, Alpa V.
    Purdue, Mark P.
    Snyder, Kirk
    Steplowski, Emily
    Yu, Kai
    Zheng, Wei
    Hankinson, Susan E.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 172 (01) : 36 - 46
  • [46] Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis
    Simon, Kelly Claire
    Munger, K. L.
    Kraft, P.
    Hunter, D. J.
    De Jager, P. L.
    Ascherio, A.
    JOURNAL OF NEUROLOGY, 2011, 258 (09) : 1676 - 1682
  • [47] 25-Hydroxyvitamin D Levels and Hypertension Rates
    Bhandari, Simran K.
    Pashayan, Shahe
    Liu, In Lu A.
    Rasgon, Scott A.
    Kujubu, Dean A.
    Tom, Thomas Y.
    Sim, John J.
    JOURNAL OF CLINICAL HYPERTENSION, 2011, 13 (03): : 170 - 177
  • [48] Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies
    Forouhi, N. G.
    Ye, Z.
    Rickard, A. P.
    Khaw, K. T.
    Luben, R.
    Langenberg, C.
    Wareham, N. J.
    DIABETOLOGIA, 2012, 55 (08) : 2173 - 2182
  • [49] Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma
    Gandini, Sara
    Boniol, Mathieu
    Haukka, Jari
    Byrnes, Graham
    Cox, Brian
    Sneyd, Mary Jane
    Mullie, Patrick
    Autier, Philippe
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (06) : 1414 - 1424
  • [50] Serum 25-hydroxyvitamin D levels and dyslipidemia: a systematic review and dose-response meta-analysis of epidemiologic studies
    Bahadorpour, Sedigheh
    Hajhashemy, Zahra
    Saneei, Parvane
    NUTRITION REVIEWS, 2022, 81 (01) : 1 - 25